Advances in Toxoplasma gondii Vaccines: Current Strategies and Challenges for Vaccine Development

KB Chu, FS Quan - Vaccines, 2021 - mdpi.com
Toxoplasmosis, caused by the apicomplexan parasite Toxoplasma gondii, is one of the most
damaging parasite-borne zoonotic diseases of global importance. While approximately one …

Insight into the current Toxoplasma gondii DNA vaccine: a review article

X Zhang, H Yuan, YS Mahmmod, Z Yang… - Expert Review of …, 2023 - Taylor & Francis
Introduction Toxoplasma gondii (T. gondii) is a widespread protozoan with significant
economic losses and public health importance. But so far, the protective effect of reported …

Immunogenicity of in-silico designed multi-epitope DNA vaccine encoding SAG1, SAG3 and SAG5 of Toxoplasma gondii adjuvanted with CpG-ODN against acute …

M Khodadadi, F Ghaffarifar, A Dalimi, E Ahmadpour - Acta Tropica, 2021 - Elsevier
The causative agent of toxoplasmosis, Toxoplasma gondii (T. gondii), is able to influence the
health of humans and other vertebrates. Toxoplasma may cause severe illness in the fetus …

REVIEW OF DNA VACCINE APPROACHES AGAINST THE PARASITE TOXOPLASMA GONDII

RC Warner, RC Chapman… - The Journal of …, 2021 - meridian.allenpress.com
Toxoplasma gondii is an apicomplexan parasite that affects both humans and livestock.
Transmitted to humans through ingestion, it is the second-leading cause of foodborne illness …

The Molecular Characterization and Immunity Identification of Trichomonas vaginalis Adhesion Protein 33 (AP33)

Z Zhang, Y Li, S Wang, L Hao, Y Zhu, H Li… - Frontiers in …, 2020 - frontiersin.org
Trichomoniasis is caused by Trichomonas vaginalis (T. vaginalis), which is a widespread
and serious sexually transmitted pathogen in humans. The procedure of T. vaginalis …

The molecular characterization and immune protection of adhesion protein 65 (AP65) of Trichomonas vaginalis

Z Zhang, X Song, Z Zhang, H Li, Y Duan, H Zhang… - Microbial …, 2021 - Elsevier
Background Adherence to the surface of the host cell is the precondition for T. vaginalis
parasitism and pathogenicity, causing urogenital infection. The AP65 of T. vaginalis …

[HTML][HTML] An Overview of DNA Vaccines Development Studies Against Toxoplasma gondii

C Gül, T Karakavuk, M Karakavuk… - Turkiye …, 2022 - turkiyeparazitolderg.org
Toxoplasma gondii (T. gondii) is an obligate intracellular parasite that can infect almost all
warm-blooded animals, including humans, and one-third of the global population is thought …

New insights for the development of efficient DNA vaccines

S Berger, Y Zeyn, E Wagner, M Bros - Microbial Biotechnology, 2024 - Wiley Online Library
Despite the great potential of DNA vaccines for a broad range of applications, ranging from
prevention of infections, over treatment of autoimmune and allergic diseases to cancer …

[HTML][HTML] Recent advances in development of nano-carriers for immunogene therapy in various complex disorders

S Shahgordi, F Oroojalian, E Hashemi… - Iranian Journal of …, 2022 - ncbi.nlm.nih.gov
Immunotherapy is a novel preference for the treatment of various complex diseases.
Considering the application of varying agents for suppression or activation of the immune …

[HTML][HTML] Preparation and immunological properties of a nanovaccine against Pseudomonas aeruginosa based on gold nanoparticles and detoxified …

F Najafzadeh, A Tanomand, A Haddadi… - Iranian Journal of Basic …, 2021 - ncbi.nlm.nih.gov
Objective (s): Pseudomonas aeruginosa is one of the most important bacterial pathogens in
immunocompromised patients, and the lipopolysaccharide (LPS) of this organism is a key …